GUPTA, RUCHIRMD NPI 1265668453 Clinician
Pain Management · PHOENIX, AZ
- MOUNTAIN VIEW HEADACHE AND SPINE INSTITUTE PLLC — PHOENIX, AZ
Group affiliation since 2019
The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.
Year: 2024 · 2023 · 2022 locked column · 2021 locked column
Provider overview · all codes · CY2024
The full analytics for this provider
PremiumThe billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.
- Payment, service & beneficiary totals — the disclosed scale, all codes
- Practice profile — focus & reach — top codes by share of services
- Office vs. facility setting mix — place-of-service code split
- Volume over five years — discrete yearly counts, no rate
- Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
- Peer positioning — code breadth — how many codes billed, vs peers
Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.
Notify me at launch → Or see a live example profile →Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services locked column | Beneficiary-episodes locked column | Avg charge locked column | Avg Medicare payment locked column |
|---|---|---|---|---|---|
| J3490 | Unclassified drugs | premium | premium | premium | premium |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | premium | premium | premium | premium |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | premium | premium | premium | premium |
| J0585 | Injection, onabotulinumtoxina, 1 unit | premium | premium | premium | premium |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | premium | premium | premium | premium |
| J1010 | Injection, methylprednisolone acetate, 1 mg | premium | premium | premium | premium |
| 96375 | Injection of additional new drug or substance into vein | premium | premium | premium | premium |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | premium | premium | premium | premium |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | premium | premium | premium | premium |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | premium | premium | premium | premium |
| J7030 | Infusion, normal saline solution , 1000 cc | premium | premium | premium | premium |
| 36410 | Insertion of needle into vein (3 years or older) | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | premium | premium | premium | premium |
| 93790 | Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | premium | premium | premium | premium |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | premium | premium | premium | premium |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | premium | premium | premium | premium |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | premium | premium | premium | premium |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | premium | premium | premium | premium |
| 99425 | Principal care management services for a single high-risk disease, each additional 30 minutes provided personally by qualified health care professional, per calendar month | premium | premium | premium | premium |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | premium | premium | premium | premium |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| 99424 | Principal care management services for a single high-risk disease, first 30 minutes provided personally by qualified health care professional, per calendar month. | premium | premium | premium | premium |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | premium | premium | premium | premium |
| J3415 | Injection, pyridoxine hcl, 100 mg | premium | premium | premium | premium |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | premium | premium | premium | premium |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | premium | premium | premium | premium |
| 93923 | Complete ultrasound study of arm and leg arteries | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | premium | premium | premium | premium |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | premium | premium | premium | premium |
| 95923 | Testing of autonomic (sympathetic) nervous system function | premium | premium | premium | premium |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | premium | premium | premium | premium |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | premium | premium | premium | premium |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | premium | premium | premium | premium |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | premium | premium | premium | premium |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | premium | premium | premium | premium |
| 96132 | Evaluation of neuropsychological test, first hour | premium | premium | premium | premium |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | premium | premium | premium | premium |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | premium | premium | premium | premium |
| J2550 | Injection, promethazine hcl, up to 50 mg | premium | premium | premium | premium |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | premium | premium | premium | premium |
| J0360 | Injection, hydralazine hcl, up to 20 mg | premium | premium | premium | premium |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | premium | premium | premium | premium |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | premium | premium | premium | premium |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | premium | premium | premium | premium |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
| J1030 | Injection, methylprednisolone acetate, 40 mg | premium | premium | premium | premium |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | premium | premium | premium | premium |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | premium | premium | premium | premium |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | premium | premium | premium | premium |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | premium | premium | premium | premium |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | premium | premium | premium | premium |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | premium | premium | premium | premium |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.